Status:
UNKNOWN
Isonicotinic Acid Hydrazide (INH) Pretreatment With Misoprostol Versus Misoprostol Alone in Missed Abortion
Lead Sponsor:
Aswan University Hospital
Conditions:
IUCD Complication
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
The primary endpoint was the success rate of adjuvant isonicotinic acid hydrazide (INH) and misoprostol versus misoprostol alone for medical termination of first-trimester pregnancy.
Detailed Description
According to the American college of obstetricians and gynecologists (2005), medical abortion is an acceptable alternative for surgical procedures in pregnant women with gestational age of less than 1...
Eligibility Criteria
Inclusion
- Gestational age less than 70 days gestation (\<10 wks)
- Hemoglobin \>10 g/dL.
- BMI between 18.5 kg/m2 and 30 kg/m2.
- Missed abortion
Exclusion
- Molar pregnancy.
- Fibroid uterus.
- Uterine anomalies.
- Coagulopathy.
- Medical disorder that contraindicate induction of abortion (e.g. heart failure).
- Previous attempts for induction of abortion in the current pregnancy.
- Allergy to misoprostol or letrozole.
- Scared uterus (previous myomectomy, cesarean section, hysterectomy and ruptured uterus).
Key Trial Info
Start Date :
September 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 30 2021
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT04500002
Start Date
September 1 2020
End Date
July 30 2021
Last Update
August 5 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aswan University Hospital
Aswān, Egypt, 81528